MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Psycho-behavioral profile of Parkinson’s disease patients with RLS: a cross sectional-study

A. MARQUES, M. Figorilli, B. Pereira, P. Derost, B. Debilly, P. Beudin, T. Vidal, F. Durif, M. Fantini (Clermont-Ferrand, France)

Meeting: 2017 International Congress

Abstract Number: 651

Keywords: Parkinsonism, Restless legs syndrome(RLS): Clinical features

Session Information

Date: Tuesday, June 6, 2017

Session Title: Restless Legs Syndrome and Other Sleep Disorders

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To determine whether RLS could be associated with a specific psycho-behavioral profile and ICDs in Parkinson’s disease (PD). 

Background: Impulse Control Disorders (ICDs) have been described in patients with idiopathic Restless Legs Syndrome (RLS) under dopaminergic therapy (1). Untreated patients with idiopathic RLS have also displayed increased impulsive choices compared to controls (2). 

Methods: Seventy-one consecutive PD patients were screened for the presence of RLS in a cross-sectional study. Sleep features were evaluated during one video-polysomnography. The frequency of ICDs, according to standard criteria, together with a broad range of psycho-behavioral features using the Ardouin Scale of Behavior in PD, were compared in patients with RLS (PD-RLS, n=28) versus without RLS (PD-noRLS, n=43). 

Results: PD patients with RLS reported significantly more ICDs than those without RLS (53% versus 27.9%, p=0.02), especially compulsive eating disorders, and a different psycho-behavioral profile with more hyperdopaminergic behaviors. The groups were comparable for age, sex ratio, occurrence of REM Sleep Behavior Disorders, and disease severity. There was no between group difference for total levodopa equivalent dose (LED) and Dopamine agonists LED. However, the durations of both disease and dopaminergic treatment were longer in the RLS group. Propensity score analyses controlling for age, gender, dose and duration of treatment, showed that RLS was an independent predictor of ICDs in PD (OR=3.85[2.36;6.50]).

Conclusions: ICDs and hyperdopaminergic behaviors are more frequently reported in PD-RLS compared to PD-no RLS, regardless of dopatherapy dose and duration, suggesting that RLS per se could be a risk factor for impulsive behaviors in PD.

References: 1. Cornelius JR, Tippmann-Peikert M, Slocumb NL et al.. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep 2010; 33: 81–87.

2. Bayard S, Yu H, Langenier MC et al. Decision making in restless legs syndrome. Mov Dis 2010; 25: 2634–2640.

To cite this abstract in AMA style:

A. MARQUES, M. Figorilli, B. Pereira, P. Derost, B. Debilly, P. Beudin, T. Vidal, F. Durif, M. Fantini. Psycho-behavioral profile of Parkinson’s disease patients with RLS: a cross sectional-study [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/psycho-behavioral-profile-of-parkinsons-disease-patients-with-rls-a-cross-sectional-study/. Accessed July 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/psycho-behavioral-profile-of-parkinsons-disease-patients-with-rls-a-cross-sectional-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley